Mepha Pharma AG - Olmesartan-Amlodipin-HCT-Mepha 40 mg/5 mg/12,5 mg, Lactab | | 67602 | | 02 | | Olmesartan-Amlodipin-HCT-Mepha 40 mg/5 mg/12,5 mg | | Lactab | | C09DX03 | | Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide | | 11.08.2020 | | |
| Composition | Filmtablette: olmesartanum medoxomilum 40 mg, amlodipinum 5 mg ut amlodipini besilas 6.93 mg, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, lactosum monohydricum 38 mg, crospovidonum, povidonum K 30, carboxymethylamylum natricum A corresp. natrium 0.42 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, E 172 (flavum), macrogolum 4000, talcum, pro compresso obducto. | Packungsbestandteile | | Comprimés filmés | | | Principe actif | Concentr. | informations additionels |
---|
Amlodipine | 5 mg | | Hydrochlorothiazide | 12.5 mg | | Olmesartanum Medoxomilum | 40 mg | Filmtablette |
| BAG: Principe actif | Concentr. |
---|
Amlodipine | 5 mg | Hydrochlorothiazide | 12.5 mg | Olmesartan Medoxomil | 40 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Flavum) | | | Carboxymethylamylum Natricum A | | | Cellulosum Microcristallinum | | | Crospovidonum | | | E 171 | | color. | E 172 | | color. | Lactose Monohydrate | 38 mg | | Macrogol | 4000 | | Magnesii Stearas | | | Poly(Alcohol Vinylicus) | | Überzug | Povidonum K | 30 | | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | | | Talcum | | |
| |
| |
|